Leading CDMO PCI Pharma Services Releases Inaugural Comprehensive ESG Report

Contributed by: Business Wire

Logo

Images

The report discloses PCI's performance, targets, and strategy to achieve nine identified impact categories. (Photo: Business Wire)

Business Wire embedded0

Tags

Medical Supplies

Biotechnology

Manufacturing

Professional Services

Health

General Health

Pharmaceutical

Environmental, Social and Governance (ESG)

Transport

Logistics/Supply Chain Management

Packaging

ESG Report

More Like This

PCI Pharma Services is investing more than $365 million in infrastructure supporting the clinical and commercial-scale final assembly and packaging of drug-device combination products utilizing advanced drug delivery systems, with an emphasis on injectable formats. (Photo: Business Wire)

PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products

Options Abound as Europe’s ESG Services Expand Rapidly

PCI becomes first drug product CDMO to navigate ICMRA multi-agency inspection process. (Photo: Business Wire)

PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection

PR Newswire associated0

XCMG Machinery Unveils Groundbreaking ESG Report, Marking a Milestone in Sustainable Business Development

PR Newswire associated0

Clario delivers substantial gains toward diversity and net-zero emission goals in second annual ESG report

PR Newswire associated0

Clario publishes third annual ESG Report, reaffirms commitment to ethical AI, workforce investment, and sustainability targets

PR Newswire associated0

POWERCHINA-Intl publishes ESG Report 2023, highlighting commitment to sustainability

Air pollution over Shanghai illustrating the climate health crisis. (Photo: Business Wire)

Global Healthcare Leaders Advance Sector Decarbonisation Ahead of COP28